|
MCM3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.968800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.349670E-02 |
| Normal-vs-Stage2 |
2.213600E-01 |
| Normal-vs-Stage3 |
1.975740E-02 |
| Normal-vs-Stage4 |
1.877020E-01 |
| Stage1-vs-Stage2 |
5.529000E-01 |
| Stage1-vs-Stage3 |
5.208400E-01 |
| Stage1-vs-Stage4 |
8.260800E-01 |
| Stage2-vs-Stage3 |
2.970400E-01 |
| Stage2-vs-Stage4 |
7.981600E-01 |
| Stage3-vs-Stage4 |
5.294400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.643800E-03 |
| Normal-vs-AfricanAmerican |
1.664090E-03 |
| Normal-vs-Asian |
5.995000E-01 |
| Caucasian-vs-AfricanAmerican |
3.091400E-01 |
| Caucasian-vs-Asian |
5.180000E-01 |
| AfricanAmerican-vs-Asian |
3.349200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.045620E-02 |
| Normal-vs-Female |
3.67679999999648E-05 |
| Male-vs-Female |
5.775800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.277900E-02 |
| Normal-vs-Extreme_Weight |
6.619600E-02 |
| Normal-vs-Obese |
3.817800E-04 |
| Normal-vs-Extreme_Obese |
6.718200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.240200E-01 |
| Normal_Weight-vs-Obese |
7.771900E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.332390E-01 |
| Extreme_Weight-vs-Obese |
2.197700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.809010E-01 |
| Obese-vs-Extreme_Obese |
3.260400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.920300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.556100E-04 |
| Normal-vs-Age(61-80Yrs) |
1.473540E-02 |
| Normal-vs-Age(81-100Yrs) |
9.741400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.541800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.996810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.985600E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.506200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.642750E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.486400E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.06980000000612E-05 |
| Normal-VS-Type2 PRCC |
5.592600E-01 |
| Normal-VS-KIRP CIMP |
1.033350E-01 |
| Normal-VS-Unclassified PRCC |
1.019180E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.68230000000747E-05 |
| Type1 PRCC-VS-KIRP CIMP |
4.007400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
2.025700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.264780E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.384000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.956600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.158000E-01 |
| Normal-vs-N1 |
1.426220E-02 |
| Normal-vs-N2 |
5.409200E-01 |
| N0-vs-N1 |
2.002000E-02 |
| N0-vs-N2 |
6.754200E-01 |
| N1-vs-N2 |
3.912800E-01 |
|
|
